News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail Digital Asset Direct

Creo Medical Group "really pleased" with first human trial of lung lesion treatment

Creo Medical Group PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 26, 2023 11:07 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Poolbeg Pharma's new NED looking at "new opportunities" for the business

Poolbeg Pharma PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 26, 2023 07:32 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

ImmuPharma "looking forward with quiet confidence" to FDA response

ImmuPharma PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 24, 2023 11:08 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Voyager Life "now capable of dealing with multinational customers"

Voyager Life PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 24, 2023 11:03 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Oxford Cannabinoid Technologies: Phase 1 approval for lead chronic pain drug

Oxford Cannabinoid Technologies Holdings PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 24, 2023 10:59 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Creo Medical Group "gaining a level of acceptance" in endoscopy

Creo Medical Group PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 23, 2023 11:15 AM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

BiVictriX Therapeutics makes 'fundamental step forward'

BlueRush Inc.

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

January 22, 2023 07:55 AM Eastern Standard Time

Video
Article thumbnail Digital Asset Direct

Oxford Cannabinoid Technologies "ready to go" after phase 1 trial submission

Oxford Cannabinoid Technologies Holdings PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

January 06, 2023 04:58 AM Eastern Standard Time

Video
Article thumbnail Digital Asset Direct

hVIVO contract the fruit of increasing Asian focus

hVIVO PLC

Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

January 04, 2023 08:37 AM Eastern Standard Time

Video
12345 ... 8